Fleet inspection and maintenance software developer Whip Around has introduced a new feature to its app that allows fleet managers to manage and track vehicle faults flagged by drivers during daily vehicle inspections. ...
As the month of May kicked off, stocks got off to a rocky start. The market slumped in response to a first quarter profit miss from eCommerce giant Amazon (NASDAQ:AMZN) and its plan to put all second-quarter earnings towards its COVID-19 response, with all three of the major U.S. indexes landing in the red on the week's final day of trading. Aside from healthcare stocks, many also came under pressure as tensions between the U.S. and China flared after the Trump administration stated that China will be held accountable for COVID-19. May 1's disappointing trading session came on the heels of the largest monthly surge for Wall Street in more than three decades. However, that's not to say investors should hold off on all new additions to their portfolios. The investing pros note that it's still possible to unmask the names poised to take off on an upward trajectory, you just...
For years, precious metals mining companies like Newmont (NYSE:NEM) and Barrick Gold (NYSE:GOLD) floundered in relative obscurity. Following the bubble bursting in the commodities sector early last decade, miners found themselves out of favor with the broader market cycle. Simply, with enthusiasm returning to equities following the Great Recession, NEM stock appeared anachronistic to Wall Street.Source: Shutterstock As you know, the novel coronavirus changed everything.Despite extreme volatility in March when the U.S. was gripped in pandemic fever, NEM stock found its footing in April. Moreover, shares are carrying that robust momentum into May, suggesting further upside. Although I'm more of a cryptocurrency fan than a goldbug, you don't want to ignore what the tape is broadcasting.InvestorPlace - Stock Market News, Stock Advice & Trading TipsYou don't need to look far to understand that Newmont, Barrick and other major gold stocks have significant upside potential. In the latest jobless claims report, the...
Biopharma shares have outperformed the broader market year-to-date, giving rise to apprehension over whether a pullback is in the offing. An analyst at BofA Securities said Friday that now is the time to go from defensive to offensive in the sector, as quarantines are winding down in several parts of the globe.The Biopharma Analyst Analyst Geoff Meacham shortlisted Eli Lilly And Co (NYSE: LLY), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Bristol-Myers Squibb Co (NYSE: BMY), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Amgen, Inc. (NASDAQ: AMGN) as biopharma stocks where he would put his money to work.The analyst has the following ratings and price targets for the shares: * Lilly: Buy/$165 * Vertex: Buy/$300 * Bristol-Myers Squibb: Buy/raised the price target from $75 to $80 * BioMarin: Buy/lifted price target from $110 to $120 * Amgen: Buy/price target increased from $265 to $2755 Reasons For BofA's Bullish Disposition BofA is increasingly bullish on...
(Bloomberg) -- President Donald Trump cast doubt on the future of his “phase one” trade deal with China, one of the biggest accomplishments of his first term, saying Friday that he’s struggling with Beijing in the wake of the global coronavirus pandemic.“Look, I’m having a very hard time with China,” Trump said in an interview on Fox & Friends. “I made a great trade deal months before this whole thing happened. And it was kicking in, you know, a month ago and starting to kick in and starting to produce and then this happens and it sort of overrides so much.”Trump’s remarks contrasted with statements from Chinese and U.S. officials earlier in the day that followed a phone call among the country’s top trade negotiators, Chinese Vice Premier Liu He, and U.S. Trade Representative Robert Lighthizer and Treasury Secretary Steven Mnuchin. They pledged to create favorable conditions for implementation of the...
The latest data analyzed by The Block Research shows that bitcoin miners made 8% more revenue in April as compared to March, thanks to a gradual recovery in bitcoin’s price.The post Bitcoin miners made $412.5 million in revenue during April, new data indicates appeared first on The Block....
